Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Significant Rise in Diabetic Ketoacidosis Incidence Linked to Slight Increase in HbA1c Levels at Type 1 Diabetes Diagnosis Among Swedish Pediatric Patients
Clinical Scorecard: Significant Rise in Diabetic Ketoacidosis Incidence Linked to Slight Increase in HbA1c Levels at Type 1 Diabetes Diagnosis Among Swedish Pediatric Patients
At a Glance
Category
Detail
Condition
Diabetic Ketoacidosis (DKA) in Type 1 Diabetes
Key Mechanisms
Metabolic acidosis at diagnosis, primarily due to DKA.
Target Population
Children diagnosed with Type 1 Diabetes in Sweden.
Care Setting
Pediatric diabetes care and management.
Key Highlights
30% of children diagnosed with T1D presented with DKA in 2025.
Severe DKA (pH < 7.1) increased from 8.4%-10% in 2021-2025.
Mean HbA1c at diagnosis increased from 92-97 mmol/mol (2007-2011) to 96-98 mmol/mol (2021-2025).
Incidence of childhood T1D doubled from 1978 to 2019.
Higher DKA presentation may indicate a more aggressive disease course.
Guideline-Based Recommendations
Diagnosis
Measure plasma glucose immediately in any child exhibiting symptoms suggestive of diabetes.
Management
Initiate insulin therapy promptly to manage hyperglycemia and prevent further DKA.
Administer intravenous fluids to correct dehydration and electrolyte imbalances.
Monitor blood glucose levels frequently to adjust insulin dosage as needed.
Monitoring & Follow-up
Regular follow-up appointments to monitor HbA1c levels and overall diabetes management.
Assess for potential complications of diabetes and DKA during follow-up visits.
Risks
HCP-delayed diagnosis may increase DKA risk.
Patient & Prescribing Data
Children diagnosed with Type 1 Diabetes.
Further investigation of modifiable risk factors associated with disease progression is warranted.
Clinical Best Practices
Comprehensive evaluation of data including age distribution and HbA1c relationship with age.
